Drug Database
ES

estrogens (Cenestin / Bijuva, Barr)

✓ Approved

Teva Pharmaceutical Industries Ltd. · ESR1

什么是 estrogens?

estrogens 是一种治疗药物,由Teva Pharmaceutical Industries Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Intravaginal、Oral (PO)。

药物档案

商品名Cenestin, Bijuva, Barr
公司Teva Pharmaceutical Industries Ltd.
分子靶点ESR1
给药途径Intravaginal, Oral (PO)
状态Approved

作用机制

分子靶点

estrogens 作用于 1 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

estrogens 针对 3 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Reproductive system and breast disordersAtrophic vulvovaginitis✓ Approved
Surgical and medical proceduresHormone replacement therapy✓ Approved
Reproductive system and breast disordersMenopausal symptoms✓ Approved

相关研究文献

PubMedCureus2026-07-27

Coinfection of Malaria, Parvovirus, Epstein-Barr Virus, Respiratory Syncytial Virus, and Lyme Disease in a Returning Traveller: A Case Report.

Shoaib Sadia S, Mohamed Mahmoud A MA, Abbasi Saddam H SH, Javed Momina M et al.

We report the case of a 36-year-old woman presenting with fever, jaundice, and haemolysis after recent travel to Ghana. She was ultimately diagnosed with concurrent infections: Plasmodium falciparum (P. falciparum), parvovirus B19, Epstein-Barr virus (EBV), respiratory syncytial virus (RSV), and Borrelia burgdorferi (Lyme disease). Her course was complicated by profound haemolysis, acute kidney injury, and persistent fever despite antimalarial therapy. This case highlights the diagnostic and therapeutic challenges of polymicrobial infections in returning travellers, the overlapping mechanisms of haemolysis, and the importance of a multidisciplinary approach to care.

PMID 42504354
阅读全文 →
PubMedCureus2026-07-27

A Case of Isolated Epstein-Barr Virus Hepatitis With Jaundice.

Al Makari Reem M RM, Mroue Zyad Z, El Dakdoukii Ghenwa K GK

Epstein-Barr virus (EBV), presenting as infectious mononucleosis (IM), affects almost all people by age 20. It has several systemic manifestations that are associated with pharyngitis and fever. We present a rare presentation of EBV infection manifesting as hepatitis and jaundice without prior IM symptoms. A 46-year-old female presented with abdominal pain and jaundice. Laboratory findings showed elevated liver enzymes and bilirubin. There was no evidence of other diseases on laboratory findings, imaging, or symptoms. EBV IgM was the only laboratory-positive value. The patient continued symptomatic treatment and fully recovered within about 10 months. EBV manifesting as isolated hepatitis occurs rarely in the population. Cases of hepatitis not preceded by IM have not been reported previously.

PMID 42504379
阅读全文 →
PubMedBiomacromolecules2026-07-27

Supramolecular Nano-Assembly of Melatonin-Conjugated Peptide as a Multifunctional Scaffold for Wound Healing Applications.

Bundel Pruthviraj P, Shounak Pranjit P, Vashisth Ankit A, Singh Yashveer Y

Wounds are one of the major socioeconomic challenges globally, mainly arising from trauma, surgery, burns, and infections. In many cases, prolonged recovery time leads to complications and requires a multifunctional approach that can target tissue regeneration and prevents infection. The supramolecular assembly of peptides yield well-defined nanoassemblies that resemble the extracellular matrix and influence cellular interactions. The peptide-based systems allow structural fine-tuning, high biocompatibility, and the ability to incorporate bioactive signals. Despite advances in peptide-based supramolecular gels for wound treatment, multifunctional peptide-based scaffolds remain relatively unexplored. In this work, we have designed a melatonin-conjugated amphiphilic peptide that self-assembles into a viscoelastic, nanofibrous gel with antibacterial and wound-healing functions. The amphiphilic nanofibers effectively disrupted bacterial membranes, and conjugated melatonin enhanced the antioxidant activity and promoted M1 to M2 macrophage polarization. The structural and biological properties of the self-assembled gel provide a promising multifunctional platform for wound management.

PMID 42503848
阅读全文 →
PubMedInorganic chemistry2026-07-27

Ce(2,2'-bipyridyl)3(SCN)3: Lanthanide Coordination- and Hydrogen-Bond-Directed Binary π-Conjugated Assemblies with Synergistic Large Birefringence and Broad Transparency.

Zhang Quan-Wei QW, Tian Zi-Han ZH, Wu Ming-Xing MX, Ma Chen-Yuan CY et al.

Exploring high-performance birefringent crystals holds paramount significance in modern optics, yet traditional candidates generally struggle to reconcile substantial birefringence with broad spectral transparency. To circumvent this long-standing bottleneck, a synergistic multifunctional-group assembly strategy has been devised to guide the rational design of birefringent crystals. Correspondingly, driven by lanthanide coordination and hydrogen bonding, two kinds of π-conjugated units were successfully incorporated into a new birefringent crystal, Ce(2,2'-bipyridyl)3(SCN)3. Synthesized via a facile solution evaporation method, Ce(2,2'-bipyridyl)3(SCN)3 was characterized by a large birefringence of 0.18@546 nm, broad transmission windows (nearly spanning 0.445-25 μm), and moderate thermal stability (up to 270 °C), making it favorable for practical applications.

PMID 42503748
阅读全文 →
PubMedGels (Basel, Switzerland)2026-07-27

A Three-Dimensional Biomimetic In Vitro Model to Simulate Schwann Cell-Mediated Peripheral Nerve Repair.

Pinkham Kristina K, Ridolfo Amelia A, Jain Avantika A, Garg Koyal K

Peripheral nerve injuries represent significant clinical challenges, often resulting in lifelong motor function loss and disability. Evidence suggests regenerating axons cannot cross nerve gaps without Schwann Cell (SC) assistance. However, FDA-approved biomaterial conduits for peripheral nerve repair lack bioactivity and structural complexity needed to facilitate SC migration. To address this, we developed a three-dimensional biomimetic in vitro model to simulate complex cellular interactions within the nerve bridge. The model features lyophilized hydrogel bioscaffolds with longitudinal channels to recapitulate the nerve microenvironment. To encourage directional SC dispersion, the top ~30% of the bioscaffold was conjugated with macrophage inflammatory protein-1α (MIP-1α). Rat SCs were seeded within no-MIP-1α- and MIP-1α-conjugated bioscaffold channels as spheroids and cultured for nine days. Histology demonstrated MIP-1α conjugation retained more SC spheroids during culture with greater cellular distributions. SC spheroid culture in MIP-1α-conjugated bioscaffold resulted in enhanced paracrine signaling characterized by increases in VEGF, ICAM-1, IL-6, and CINC-1 production, alongside downregulation of IL-1β, IL-10, and IL-13. The SC-derived pro-inflammatory and pro-angiogenic mediators did not inhibit NSC-34 motor neurite extension compared to controls. This study establishes an in vitro model that serves as both a screening platform and mechanistic tool, advancing our understanding of peripheral nerve repair.

PMID 42505288
阅读全文 →
PubMedJournal of medical virology2026-07-27

An Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Serology Test Strip for Nasopharyngeal Carcinoma Risk Screening.

Warner Benjamin E BE, Patel Japan J, Satterwhite Rebecca R, Wang Renwei R et al.

Antibodies to Epstein-Barr virus (EBV) proteins can predict nasopharyngeal carcinoma (NPC) risk. We previously defined a prototype EBNA1 protein panel and multiplex immunoblot assay that distinguishes NPC risk several years pre-diagnosis. Assay throughput and specificity are critical to effectively implement a population-level screening program. Here, we developed a strip test assay-EBNA1 SeroStrip-HT-with an objective to increase throughput and maximize specificity. EBNA1 full-length (FL) and glycine-alanine repeat deletion mutants (dGAr) were purified from insect and mammalian cells to screen serum IgA/IgG from prospective cohorts in Singapore and Shanghai, China, with known time intervals to NPC diagnosis. Twenty pre-diagnostic sera within 4 years to diagnosis were compared to 96 healthy controls using a nested case-control study design. IgA to mammalian-derived EBNA1 dGAr achieved 85.0% sensitivity and 94.8% specificity (AUC, 0.939) for NPC status. IgA to insect-derived EBNA1 dGAr showed the same sensitivity (85.0%) and similar specificity (93.8%) (AUC, 0.941). IgA to insect-derived EBNA1 FL had a higher 90% sensitivity, but lower 91.7% specificity (AUC, 0.940). Combining EBNA1 FL and dGAr results showed that subjects positive for both proteins had a 243.67 odds ratio for NPC incidence compared to double-negative scores. This study demonstrated the efficacy of EBNA1 SeroStrip-HT for NPC risk assessment and stratification in high- and intermediate-risk populations, yielding high accuracy and a 12-fold increased throughput over the prototype. The insect system was appropriate for large-scale production of purified EBNA1. Larger, geographically diverse cohorts are warranted to confirm these results, especially in low-incidence populations.

PMID 42504130
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多estrogens